500087 and CIPLA.NS Related Headlines
Go Back- Cipla wins FDA approval for generic Advair Diskus in all strengths
- Cipla Receives U.S. FDA Approval for Generic Advair Diskus®
- Cipla receives FDA approval for first generic Ventolin HFA
- Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
- Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
- Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
500087 and CIPLA.NS Related Press Releases
Go Back- Cipla Receives U.S. FDA Approval for Generic Advair Diskus®
- Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
- Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
- Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
